Evidence has indicated that BDNF expression levels are significantly elevated in cancer patients, while the modified forms of tropomyosin receptor kinase B (TrkB), which interacts with BDNF, are involved in various stages of cancer development, including the growth, maturation, migration, and invasion of cancer cells [11]. This evidence concerns the gene NTRK2 and cancer.